Maturity-onset diabetes of the young: update and perspectives on diagnosis and treatment

키워드

참고문헌 (73)

1. Yang Y, "Monogenic diabetes : what it teaches us on the common forms of type 1 and type 2 diabetes", Endocr Rev, 37, pp.190~222 (2016)
2. Steck AK, "Review on monogenic diabetes", Curr Opin Endocrinol Diabetes Obes, 18, pp.252~258 (2011)
3. Tattersall RB, "Mild familial diabetes with dominant inheritance", Q J Med, 43, pp.339~357 (1974)
4. Ellard S, "Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young", Diabetologia, 51, pp.546~553 (2008)
5. Froguel P, "Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus", Nature, 356, pp.162~164 (1992)
6. Yamagata K, "Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young(MODY1)", Nature, 384, pp.458~460 (1996)
7. Horikawa Y, "Mutation in hepatocyte nuclear factor-1 beta gene(TCF2)associated with MODY", Nat Genet, 17, pp.384~385 (1997)
8. 김성훈, "Maturity-Onset Diabetes of the Young: What Do Clinicians Need to Know?", Diabetes and Metabolism Journal, 39(6), pp.468~477 (2015), 대한당뇨병학회[DOI]
9. Prudente S, "Loss-of-function mutations in appl1 in familial diabetes mellitus", Am J Hum Genet, 97, pp.177~185 (2015)
10. Urakami T, "Maturity-onset diabetes of the young(MODY) : current perspectives on diagnosis and treatment", Diabetes Metab Syndr Obes, 12, pp.1047~1056 (2019)
11. Henzen C, "Monogenic diabetes mellitus due to defects in insulin secretion", Swiss Med Wkly, 142, pp.w13690~ (2012)
12. Shepherd M, "Systematic population screening, using biomarkers and genetic testing, identifies 2.5% of the U.K. pediatric diabetes population with monogenic diabetes", Diabetes Care, 39, pp.1879~1888 (2016)
13. Fajans SS, "Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young", N Engl J Med, 345, pp.971~980 (2001)
14. Shields BM, "Maturity-onset diabetes of the young (MODY): how many cases are we missing?", Diabetologia, 53, pp.2504~2508 (2010)
15. Osbak KK, "Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia", Hum Mutat, 30, pp.1512~1526 (2009)
16. Steele AM, "Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation : observational case control studies", PLoS One, 8, pp.e65326~ (2013)
17. Kavvoura FK, "Maturity onset diabetes of the young: clinical characteristics, diagnosis and management", Pediatr Endocrinol Rev, 10, pp.234~242 (2013)
18. Estalella I, "Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain", Clin Endocrinol(Oxf), 67, pp.538~546 (2007)
19. Codner E, "Mild fasting hyperglycemia in children : high rate of glucokinase mutations and some risk of developing type 1 diabetes mellitus", Pediatr Diabetes, 10, pp.382~388 (2009)
20. Hwang JS, "Genetic and clinical characteristics of Korean maturity-onset diabetes of the young(MODY)patients", Diabetes Res Clin Pract, 74, pp.75~81 (2006)
21. McDonald TJ, "Maturity onset diabetes of the young : identification and diagnosis", Ann Clin Biochem, 50, pp.403~415 (2013)
22. Pontoglio M, "Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice", J Clin Invest, 101, pp.2215~2222 (1998)
23. Boileau P, "Decreased glibenclamide uptake in hepatocytes of hepatocyte nuclear factor-1alpha-deficient mice: a mechanism for hypersensitivity to sulfonylurea therapy in patients with maturity-onset diabetes of the young, type 3 (MODY3)", Diabetes, 51(Suppl 3), pp.S343~S348 (2002)
24. Hattersley AT, "ISPAD Clinical Practice Consensus Guidelines 2018 : the diagnosis and management of monogenic diabetes in children and adolescents", Pediatr Diabetes, 19(Suppl 27), pp.47~63 (2018)
25. Colclough K, "Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia", Hum Mutat, 34, pp.669~685 (2013)
26. Ellard S, "Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha(HNF1A)and 4 alpha(HNF4A)in maturity-onset diabetes of the young", Hum Mutat, 27, pp.854~869 (2006)
27. Yamagata K, "Overexpression of dominant-negative mutant hepatocyte nuclear fctor-1 alpha in pancreatic beta-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced beta-cell proliferation, and diabetes", Diabetes, 51, pp.114~123 (2002)
28. Shepherd M, "Predictive genetic testing in maturity-onset diabetes of the young(MODY)", Diabet Med, 18, pp.417~421 (2001)
29. Pontoglio M, "HNF1alpha controls renal glucose reabsorption in mouse and man", EMBO Rep, 1, pp.359~365 (2000)
30. Steele AM, "Increased all-cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene", Diabet Med, 27, pp.157~161 (2010)
31. Pearson ER, "Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection", Diabetologia, 48, pp.878~885 (2005)
32. Pearson ER, "Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations : evidence for pharmacogenetics in diabetes", Diabet Med, 17, pp.543~545 (2000)
33. Shepherd M, "No deterioration in glycemic control in HNF-1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas", Diabetes Care, 26, pp.3191~3192 (2003)
34. Shepherd M, "A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients", Diabet Med, 26, pp.437~441 (2009)
35. Stoffel M, "The maturity-onset diabetes of the young(MODY1)transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism", Proc Natl Acad Sci U S A, 94, pp.13209~13214 (1997)
36. Frayling TM, "beta-cell genes and diabetes : molecular and clinical characterization of mutations in transcription factors", Diabetes, 50(Suppl 1), pp.S94~S100 (2001)
37. Lehto M, "Mutation in the HNF-4alpha gene affects insulin secretion and triglyceride metabolism", Diabetes, 48, pp.423~425 (1999)
38. Barbacci E, "Variant hepatocyte nuclear factor 1 is required for visceral endoderm specification", Development, 126, pp.4795~4805 (1999)
39. Bingham C, "Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1 beta", Kidney Int, 57, pp.898~907 (2000)
40. Edghill EL, "Hepatocyte nuclear factor-1beta gene deletions : a common cause of renal disease", Nephrol Dial Transplant, 23, pp.627~635 (2008)
41. Bingham C, "Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease", Am J Hum Genet, 68, pp.219~224 (2001)
42. Bellanne-Chantelot C, "Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations", Ann Intern Med, 140, pp.510~517 (2004)
43. Edghill EL, "Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation : support for a critical role of HNF-1beta in human pancreatic development", Diabet Med, 23, pp.1301~1306 (2006)
44. Cerf ME, "Transcription factors regulating beta-cell function", Eur J Endocrinol, 155, pp.671~679 (2006)
45. Gragnoli C, "IPF-1", MODY4 gene missense mutation in an Italian family with type 2 and gestational diabetes, 2005, pp.54, 983~988
46. Stoffers DA, "Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence", Nat Genet, 15, pp.106~110 (1997)
47. Nicolino M, "A novel hypomorphic PDX1 mutation responsible for permanent neonatal diabetes with subclinical exocrine deficiency", Diabetes, 59, pp.733~740 (2010)
48. Rubio-Cabezas O, "Homozygous mutations in NEUROD1 are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities", Diabetes, 59, pp.2326~2331 (2010)
49. Neve B, "Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function", Proc Natl Acad Sci U S A, 102, pp.4807~4812 (2005)
50. Raeder H, "Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction", Nat Genet, 38, pp.54~62 (2006)
51. Torsvik J, "Mutations in the VNTR of the carboxyl-ester lipase gene(CEL)are a rare cause of monogenic diabetes", Hum Genet, 127, pp.55~64 (2010)
52. Jonsson J, "Insulin-promot er-factor 1 is required for pancreas development in mice", Nature, 371, pp.606~609 (1994)
53. Plengvidhya N, "PAX4 mutations in Thais with maturity onset diabetes of the young", J Clin Endocrinol Metab, 92, pp.2821~2826 (2007)
54. Edghill EL, "Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood", Diabetes, 57, pp.1034~1042 (2008)
55. Borowiec M, "Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction", Proc Natl Acad Sci U S A, 106, pp.14460~14465 (2009)
56. Kapoor RR, "Hyperinsulinaemic hypoglycaemia", Arch Dis Child, 94, pp.450~457 (2009)
57. Bowman P, "Heterozygous ABCC8 mutations are a cause of MODY", Diabetologia, 55, pp.123~127 (2012)
58. Liu L, "Mutations in KCNJ11 are associated with the development of autosomal dominant, early-onset type 2 diabetes", Diabetologia, 56, pp.2609~2618 (2013)
59. Thanabalasingham G, "Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young", Diabetes Care, 35, pp.1206~1212 (2012)
60. Vaxillaire M, "Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes", Endocr Rev, 29, pp.254~264 (2008)
61. Shields BM, "The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes", Diabetologia, 55, pp.1265~1272 (2012)
62. Besser RE, "Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}", hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes, 2011, pp.34, 286~291
63. Reiner AP, "Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein", Am J Hum Genet, 82, pp.1193~1201 (2008)
64. Park SS, "Identifying pathogenic variants of monogenic diabetes using targeted panel sequencing in an east Asian population", J Clin Endocrinol Metab (2019)
65. Hattersley AT, "Precision diabetes : learning from monogenic diabetes", Diabetologia, 60, pp.769~777 (2017)
66. Bansal V, "Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals", BMC Med, 15, pp.213~ (2017)
67. Xu JY, "Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients", Eur J Hum Genet, 13, pp.422~427 (2005)
68. Iwasaki N, "Mutations in the hepatocyte nuclear factor-1alpha", MODY3 gene in Japanese subjects with early-and late-onset NIDDM, 1997, pp.46, 1504~1508
69. Nishigori H, "Mutations in the hepatocyte nuclear factor-1 alpha gene(MODY3)are not a major cause of early-onset non-insulin-dependent(type 2)diabetes mellitus in Japanese", J Hum Genet, 43, pp.107~110 (1998)
70. Tonooka N, "High frequency of mutations in the HNF-1alpha gene in non-obese patients with diabetes of youth in Japanese and identification of a case of digenic inheritance", Diabetologia, 45, pp.1709~1712 (2002)
71. Tanaka D, "Exome sequencing identifies a new candidate mutation for susceptibility to diabetes in a family with highly aggregated type 2 diabetes", Mol Genet Metab, 109, pp.112~117 (2013)
72. Shim YJ, "Identification of candidate gene variants in Korean MODY families by whole-exome sequencing", Horm Res Paediatr, 83, pp.242~251 (2015)
73. Johansson S, "Exome sequencing and genetic testing for MODY", PLoS One, 7, pp.e38050~ (2012)

관련 논문AI추천